Trial intelligence / Profile preview

Intestinal Microbiota Transplantation for Chronic Hepatitis B

NCT03429439Unknown

Sponsor
Xiamen University Zhongshan Hospital
Start
Dec 2017
Primary completion
Oct 2020
Countries
1
01

Overview

Randomised, open-label trial in Chronic Hepatitis B (CHB) (2 arms), sponsored by Xiamen University Zhongshan Hospital. Primary endpoint: Change of serum hepatitis B virus e antigen level at 6 months. Status: unknown.

02

Conditions

Chronic Hepatitis B (CHB)

Beyond the preview

Go deeper on NCT03429439.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03429439.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call